Fort Lauderdale Airport

Showing 906 articles
Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Business

CSL's 34% Plunge: A Buying Opportunity or a Value Trap?

After a bruising year that saw its shares tumble by a third, biotech giant CSL is back in the spotlight. We delve beyond the headline numbers, examining valuation models and market sentiment to assess if the sell-off has created a compelling entry point for long-term investors.

Business

Apple vs. Meta: A Tale of Two Tech Titans in the Magnificent Seven

As earnings season unfolds, Apple and Meta Platforms both posted impressive results, but their paths diverge sharply. Apple's growth reaccelerates on iPhone strength, while Meta's robust outlook is shadowed by soaring AI investments. The debate over which stock offers the better value is heating up.